Drawing for YUVIPTA

USPTO serial 90541512

YUVIPTA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
RIBAUDO, MICHELLE RACHEL
Law office
TMO LAW OFFICE 126- EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with YUVIPTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Willsey

Peter J. Willsey BROWN RUDNICK LLP601 THIRTEENTH STREET NW SUITE 600WASHINGTON, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; pharmaceutical preparations for the treatment and prevention of rhinitis; pharmaceutical preparations for the treatment and prevention of Behcet's disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of metastasis; pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; pharmaceutical preparations for the treatment and prevention of kidney diseases and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 7, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 5, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 5, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 17, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2023CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 30, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 30, 2023EX3GSOU EXTENSION 3 GRANTED—
Jan 30, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 13, 2023IUAFUSE AMENDMENT FILED—
Jan 13, 2023EXT3SOU EXTENSION 3 FILED—
Jan 13, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 14, 2022EX2GSOU EXTENSION 2 GRANTED—
Dec 14, 2022EXT2SOU EXTENSION 2 FILED—
Dec 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 14, 2022ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 22, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 18, 2022EX1GSOU EXTENSION 1 GRANTED—
Mar 18, 2022EXT1SOU EXTENSION 1 FILED—
Mar 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 21, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 28, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2021APETASSIGNED TO PETITION STAFF—
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Sep 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2021DOCKASSIGNED TO EXAMINER—
May 24, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 26, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance